ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,277.51
0.80%
Dow Jones
38,686.32
1.51%
US Dollar vs MXN
17.2416
1.48%
Brent Oil
81.235
0.53%
Bitcoin
69,092.00
1.98%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Carisma Therapeutics Inc (CARM)

  7. Carisma Therapeutics Inc (CARM) Noticias

CARM

Carisma Therapeutics (CARM)

Carisma Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CARM
FechaHoraFuenteTítuloSímboloCompañía
30/05/202406:30PR Newswire (US)Carisma Therapeutics to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:CARMCarisma Therapeutics Inc
28/05/202418:39Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:CARMCarisma Therapeutics Inc
16/05/202406:30PR Newswire (US)Carisma Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of CT-0525, a Novel HER2-Targeting CAR-MonocyteNASDAQ:CARMCarisma Therapeutics Inc
09/05/202406:52Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CARMCarisma Therapeutics Inc
09/05/202406:41Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CARMCarisma Therapeutics Inc
09/05/202406:30PR Newswire (US)Carisma Therapeutics Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:CARMCarisma Therapeutics Inc
08/05/202410:45Business WireCarmila: Withdrawal of funds for the liquidity contractNASDAQ:CARMCarisma Therapeutics Inc
08/05/202410:45Business WireCarmila: Réduction des moyens du contrat de liquiditéNASDAQ:CARMCarisma Therapeutics Inc
08/05/202406:30PR Newswire (US)Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024NASDAQ:CARMCarisma Therapeutics Inc
07/05/202410:45Business WireCARMILA : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
07/05/202410:45Business WireCARMILA: Information Concerning the Total Number of Voting Rights and ShareNASDAQ:CARMCarisma Therapeutics Inc
06/05/202406:30PR Newswire (US)Carisma Therapeutics to Participate in The Citizens JMP Life Sciences ConferenceNASDAQ:CARMCarisma Therapeutics Inc
02/05/202406:30PR Newswire (US)Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical OfficerNASDAQ:CARMCarisma Therapeutics Inc
24/04/202416:05PR Newswire (US)Carisma Therapeutics Announces Upcoming Presentation at the American Society of Clinical Oncology (ASCO) 2024 Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
24/04/202411:43Business WireCarmila: Launch of a Share Buyback Program for €10 MillionNASDAQ:CARMCarisma Therapeutics Inc
24/04/202411:43Business WireCarmila : Lancement d’un programme de rachat d’actions pour 10 millions d’eurosNASDAQ:CARMCarisma Therapeutics Inc
22/04/202415:35PR Newswire (US)Carisma Therapeutics to Present New Data at the American Society of Gene and Cell Therapy (ASGCT) Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
17/04/202410:45Business WireCarmila : Information financière au 31 mars 2024NASDAQ:CARMCarisma Therapeutics Inc
17/04/202410:45Business WireCarmila: First-quarter 2024 Financial InformationNASDAQ:CARMCarisma Therapeutics Inc
05/04/202410:45Business WireCarmila: Information Concerning the Total Number of Voting Rights and Share, Provided Pursuant to Article L.233-8 II of the Code de commerce (French Commercial Code) and Article 223-16 of the Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
05/04/202410:45Business WireCarmila : Informations relatives au nombre total de droits de vote et d’actions prévues par l’article L.233-8 II du Code de commerce et l’article 223-16 du Règlement général de l’Autorité des marchés financiersNASDAQ:CARMCarisma Therapeutics Inc
03/04/202406:00PR Newswire (US)Carisma Therapeutics to Present at Upcoming ConferencesNASDAQ:CARMCarisma Therapeutics Inc
01/04/202407:35PR Newswire (US)Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:CARMCarisma Therapeutics Inc
01/04/202406:00PR Newswire (US)Carisma Therapeutics Announces Changes to its Board of DirectorsNASDAQ:CARMCarisma Therapeutics Inc
21/03/202416:00PR Newswire (US)Carisma Announces Upcoming Presentations at the American Association for Cancer Research (AACR) Annual MeetingNASDAQ:CARMCarisma Therapeutics Inc
15/03/202411:45Business WireCARMILA : INFORMATION RELATIVE A LA REMUNERATION DES DIRIGEANTS MANDATAIRES SOCIAUXNASDAQ:CARMCarisma Therapeutics Inc
15/03/202411:45Business WireCarmila: Information Relating to Executive Corporate Officer CompensationNASDAQ:CARMCarisma Therapeutics Inc
15/03/202411:45Business WireCarmila : Communiqué de mise à disposition du Document d’enregistrement universel 2023NASDAQ:CARMCarisma Therapeutics Inc
15/03/202411:45Business WireCarmila: Filing of the 2023 Universal Registration DocumentNASDAQ:CARMCarisma Therapeutics Inc
08/03/202410:45Business WireCORRECTING and REPLACING: Carmila: Changes in the composition of the Board of Directors following the meeting of the Board of Directors on 7 March 2024NASDAQ:CARMCarisma Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:CARM

Su Consulta Reciente

BIT
UC3S88
Unicredit Bank
NASDAQ
FUFU
BitFuFu
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados